[Interpretation of the Japanese guidance for pediatric familial hypercholesterolemia 2017].

Wen, W H; Wu, W F; Wang, X; Wu, Y; Kuang, Z M; Wang, L Y

Wen, W H; Wu, W F; Wang, X; Wu, Y; Kuang, Z M; Wang, L Y.

Afiliação

Wen WH; Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Wu WF; Emergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Wang X; Emergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Wu Y; Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Kuang ZM; Department of Hyptension, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Wang LY; Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

Zhonghua Xin Xue Guan Bing Za Zhi ; 47(5): 417-420, 2019 May 24.

Article em Zh | MEDLINE | ID: mdl-31142091

Assuntos

Hiperlipoproteinemia Tipo II; Criança; Humanos; Hiperlipoproteinemia Tipo II/terapia; Guias de Prática Clínica como Assunto

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperlipoproteinemia Tipo II Tipo de estudo: Guideline Limite: Child / Humans Idioma: Zh Revista: Zhonghua Xin Xue Guan Bing Za Zhi Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google